G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 27.75 SEK 3.74% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Total Liabilities & Equity Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Total Liabilities & Equity
kr303.4m
CAGR 3-Years
42%
CAGR 5-Years
48%
CAGR 10-Years
25%
AddLife AB
STO:ALIF B
Total Liabilities & Equity
kr12.7B
CAGR 3-Years
45%
CAGR 5-Years
37%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Total Liabilities & Equity
kr6.1B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Total Liabilities & Equity
kr4.9B
CAGR 3-Years
48%
CAGR 5-Years
29%
CAGR 10-Years
23%
MedCap AB (publ)
STO:MCAP
Total Liabilities & Equity
kr1.9B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
13%
M
Magle Chemoswed Holding AB
STO:MAGLE
Total Liabilities & Equity
kr273m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Total Liabilities & Equity?
Total Liabilities & Equity
303.4m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Total Liabilities & Equity amounts to 303.4m SEK.

What is Genovis AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
25%

Over the last year, the Total Liabilities & Equity growth was 44%. The average annual Total Liabilities & Equity growth rates for Genovis AB have been 42% over the past three years , 48% over the past five years , and 25% over the past ten years .

Back to Top